The Managed Care Review BoardTM
Analysis of Current and Emerging Therapies for Insomnia
Live Webcast Dates
September 11, 2013 2:00 - 4:00 PM EDT
September 24, 2013 11:30 AM- 1:30 PM EDT
Please use the link at the bottom of this page to register.
WHO SHOULD ATTEND?
- Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
- Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for insomnia including: physicians, pharmacists, registered nurses, and case managers
STATEMENT OF NEED/PROGRAM OVERVIEW
Insomnia is a leading cause of absenteeism, accidents, and errors in the workplace. Overall direct and indirect costs related to insomnia exceed $30 billion annually. A significant portion of these costs are attributable to patients with conditions comorbid to insomnia, which include mood and anxiety disorders; chronic pain; respiratory, urinary, and neurologic conditions; diabetes mellitus; and cardiovascular disease.
Through the use of new genetic tools, researchers are rapidly developing a better understanding of the basic science underlying sleep and wake behavior. Novel approaches that selectively target newly discovered systems related to insomnia have demonstrated efficacy in clinical studies. Some of these new approaches regulate sleep and wake behavior by taking advantage of the circadian rhythmicity of specific signaling systems in the central nervous system (CNS).
Because of the large volume of patients they manage, MCOs and other payers are in an excellent position to improve outcomes for patients with insomnia. By enhancing their knowledge of emerging science, pathophysiology, and emerging agents and by improving coordination of care, managed care professionals can reduce the health care burden associated with insomnia.
EDUCATIONAL OBJECTIVES
- Use knowledge of the underlying pathophysiology of sleep and wake behavior to recommend optimal treatments for patients with insomnia
- Explain new scientific approaches to regulate sleep and wake behavior through the circadian rhythmicity of signaling systems in the central nervous system
- Evaluate recent clinical studies on novel approaches for treating insomnia that selectively target newly discovered systems
- Outline the direct and indirect costs related to insomnia as a leading cause of absenteeism, accidents, and errors in the workplace
- Apply benefit design methodologies that MCOs can implement to improve the overall value for the treatment of insomnia
- Provide accurate and appropriate counsel as part of the treatment team
- Provide appropriate care and counsel for patients and their families
|
Albert Tzeel, MD, MHSA
Regional Medical Director, Senior Products Humana, Inc. |
|
Carl V. Asche, PhD
Director and Research Professor Center for Outcomes Research University of Illinois College of Medicine at Peoria |
|
James Kenney, Jr., RPh, MBA
Pharmacy Operations Manager Harvard Pilgrim Healthcare, Inc. |
|
Andrew Krystal, MD, MS
Director of the Insomnia and Sleep Research Program Duke University School of Medicine |
WEBCAST DATES AND TIMES
September 11, 2013 2:00 - 4:00 PM EDT
September 24, 2013 11:30 AM - 1:30 PM EDT
WEBCAST AGENDA
Introduction - Initial Commentary From Activity Leader
Albert Tzeel, MD, MHSA
Clinical Benefits Overview and Practice Guidelines Review
Andrew Krystal, MD, MS
Treatment Options Analysis
James Kenney, Jr., RPh, MBA
Faculty Idea Exchange
Health Economics and Pharmacoeconomics Assessment
Carl V. Asche, PhD
Benefit Design Considerations
Albert Tzeel, MD, MHSA
Faculty Idea Exchange
Audience Question and Answer Session
Closing Comments
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
|
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0809-9999-13-292-L01-P)
Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Type of Activity: Application
Nursing Continuing Education
Credit Designation
This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine.
Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A statement of credit will be issued only upon receipt of a completed online activity evaluation form.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Fee Information
There is no fee for this educational activity.
Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.x, and Google Chrome 10 and up. Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net
Click here to register.
Click here to view technical requirements for viewing the webcasts and to test your system.